Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma

NCT01609803 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01609803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2016
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar childhood rhabdomyosarcoma, embryonal childhood rhabdomyosarcoma, previously treated childhood rhabdomyosarcoma, previously untreated childhood rhabdomyosarcoma, recurrent childhood rhabdomyosarcoma